MedPath

ECT and Memantine.

Recruiting
Conditions
Electroconvulsive therapyCognitive side effectsMemantineElectroconvulsieve therapieCognitieve bijwerkingenMemantineDepression Depressie
Registration Number
NL-OMON27602
Lead Sponsor
Parnassia Psychomedical Center The HagueErasmus University Medical Center Rotterdam, dept of Psychiatry
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

DSM-IV criteria for unipolar or bipolar depression and a clinical indication for electroconvulsive
treatment (ECT).

Exclusion Criteria

Patients with organic brain syndrome, Mini-Mental State Exam score lower than 24, schizophrenia,
schizoaffective disorder, use of lithium or inadequate command of the Dutch language will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scores on a standard cognitive testbattery. This test is administered before, during and after ECT and at follow-up. This testbattery has been proven to be sensitive to cognitive side-effects of<br>depression and also for the ECT effects in depression.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath